Curanex Stock Sinks Toward 31 Cents as Nasdaq Clock Ticks
Curanex Pharmaceuticals Inc shares fell on Friday, leaving the small drug developer well below Nasdaq’s $1 minimum bid threshold as investors weighed a thinly traded stock, a still-preclinical pipeline and a broader selloff in biotechnology. The stock last traded at $0.3104, down 2.16 cents, or about 6.5%, from the prior close. It opened at $0.3224, touched $0.3233 and fell as low as $0.3089, with volume of 99,708 shares and a market value of about $8.8 million. The SPDR S&P Biotech ETF was down about 3.6%, while the iShares Nasdaq Biotechnology ETF slipped about 1.4%.